|
Showing 1 - 5 of
5 matches in All Departments
The National Cancer Policy Forum of the National Academies of
Sciences, Engineering, and Medicine convened a virtual workshop in
March 2021 to examine the existing evidence base on how the Patient
Protection and Affordable Care Act (ACA) has altered the landscape
of cancer prevention and care delivery in the United States. The
workshop featured presentations and discussions reviewing the
effects of the ACA on people at risk for or living with cancer and
providing insight into remaining policy challenges that could
inform future efforts to improve and support the delivery of
high-quality cancer care across the care continuum. This
publication provides a high-level summary of the discussions
presented during the workshop. Table of Contents Front Matter
Proceedings of a Workshop Appendix A: Statement of Task Appendix B:
Workshop Agenda
Despite advances in the delivery of high-quality cancer care and
improvements in patient outcomes in recent years, disparities in
cancer incidence, care, and patient outcomes persist. To examine
opportunities to improve health equity across the cancer care
continuum, the National Cancer Policy Forum and the Roundtable on
the Promotion of Health Equity hosted a public workshop, Promoting
Health Equity in Cancer Care, on October 25 and October 26, 2021.
This virtual workshop featured presentations and panel discussions
on topics that included: opportunities to improve equitable access
to affordable, high-quality cancer care; strategies to identify and
address the intersectionality of structural racism and implicit
bias in cancer care delivery; the potential for quality measurement
and payment mechanisms to incentivize health equity in cancer care
delivery; and clinical practice data collection efforts to better
assess and care for people living with and beyond cancer. This
publication summarizes the presentation and discussion of the
workshop. Table of Contents Front Matter Proceedings of a Workshop
Appendix A: Statement of Task Appendix B: Workshop Agenda
The COVID-19 pandemic has led to dramatic adjustments in cancer
care delivery and cancer research. To examine these changes, the
National Cancer Policy Forum of the National Academies of Sciences,
Engineering, and Medicine convened a virtual workshop, Innovation
in Cancer Care and Cancer Research in the Context of the COVID-19
Pandemic, in July 2021. Workshop speakers considered the lessons
learned from these adaptations in order to improve the delivery of
high-quality cancer care and the conduct of cancer clinical trials
in the post-pandemic era. This Proceedings of a Workshop highlights
presentations and discussions from the workshop. Table of Contents
Front Matter Proceedings of a Workshop Appendix A: Statement of
Task Appendix B: Workshop Agenda
Cancer treatment can lead to an array of significant short- and
long-term physical, psychosocial, and socioeconomic consequences
for patients and their families. To examine the opportunities to
prevent and mitigate the adverse effects of cancer treatment, the
National Academies of Sciences, Engineering, and Medicine hosted a
virtual workshop, Addressing the Adverse Consequences of Cancer
Treatment, in November 2020. This workshop was convened by the
Academies' National Cancer Policy Forum in collaboration with the
Forum on Aging, Disability, and Independence. Workshop
presentations and discussions described the range of adverse
effects that patients with cancer may experience across the life
course, and highlighted potential strategies to improve quality of
life for cancer survivors and their families. Table of Contents
Front Matter Proceedings of a Workshop Appendix A: Statement of
Task Appendix B: Workshop Agenda
Companies today are operating in a more complex and competitive
environment where traditional models for doing business are no
longer sufficient and expectations of business are growing both
internally and externally. Many companies have long and robust
histories of contributing to their communities as well as to more
global societal needs, but this has been done primarily and
historically through philanthropy and more traditional corporate
social responsibility. However, companies are increasingly seeking
greater alignment of these activities with their business interests
in order to increase their value proposition. These same companies
are also under increased pressure to build their business in a
sustainable manner through innovative approaches. The National
Academies of Sciences, Engineering, and Medicine convened a
workshop to explore the concept of shared value for global health
and safety stakeholders in both the public and private sectors;
roles, responsibilities, incentives, and opportunities for
different stakeholders engaging in global health and safety
initiatives in low- and middle-income countries; and the potential
of partnerships and collaboration for improved outcomes for all
stakeholders, including the communities they serve. Participants
considered potential opportunities for creating shared value for
all organizations, specifically the creation and impact of shared
value through an organization's core products and services, through
employee health and wellness programs, and through community or
population health investments. This report summarizes the
presentations and discussions from the workshop. Table of Contents
Front Matter 1 Introduction 2 Shared Value: Understanding Its
Evolution and Opportunities to Improve Global Health 3 Linking
Performance and Investments in Health 4 The Roles of Corporate
Philanthropy, Corporate Social Responsibility, and Shared Value 5
The Journey to Shared Value 6 Impacts of Shared Value on
Partnerships and Other Stakeholders 7 Measuring and Reporting
Corporate Impact References Appendix A: Applying Shared Value
Principles to Improve Global Health Appendix B: Workshop Agenda
Appendix C: Speaker Biographical Sketches
|
You may like...
It: Chapter 1
Bill Skarsgård
Blu-ray disc
R149
R49
Discovery Miles 490
|